Up 33% YTD, Will Rocket Lab Hit a New High This Year?

Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) in 2026 has been one of the most electric setups in the market. Shares are up 45.71% year to date and 184.18% over the past year, yet the stock sits roughly 29% below the May peak after a violent pullback.

My 24/7 Wall St. price target for Rocket Lab is $119.58, implying 17.64% upside from $101.65. Recommendation: buy, with moderate confidence.

24/7 Wall St. Price Target Summary

A Wild Ride From $44 to $151 and Back

Rocket Lab tore from around $44.60 in July 2025 to a 52-week high of $151 in May 2026 before giving back 29.15% over the last month.

Fundamentals remained strong. Q1 2026 revenue hit $200.35 million, up 63.5% year over year, beating consensus by 5.77%, with EPS of -$0.07 against a -$0.0787 estimate. Non-GAAP gross margin expanded to 43% from 33.4% a year prior, and backlog jumped to $2.20 billion. Recent Reddit chatter has been dominated by an Iridium acquisition narrative and the pending Neutron debut, keeping retail engagement elevated.

The Case for $155 and Higher

Our bull scenario points to $155.76, a 53.23% total return. Bulls have three catalysts. First, Neutron. CEO Peter Beck reaffirmed on the Q1 call that “current progress is keeping our aggressive schedule towards the first launch later this year”, and Rocket Lab just booked its largest contract ever, five dedicated Neutron flights plus three Electrons through 2029.

Second, defense. Selection alongside Raytheon for the Golden Dome Space-Based Interceptor program, layered on the $816 million SDA Tranche 3 award, gives structural exposure to the highest-priority US space budgets.

Third, vertical integration. Beck stated: “Vertically integrating important subsystems improves cost structure and gives a competitive advantage.” Bookings support it, with 31 Electron/HASTE missions signed in Q1 alone.

What Could Push RKLB Back to $92

The bear case targets $92.81, a -8.69% return. The primary risk is valuation. Rocket Lab trades at 88.63 times trailing sales and 27 times book, extraordinary multiples resting on -22.4% operating margins.

Free cash flow was -$321.8 million in 2025 and dilution continues, with $450 million raised via ATM in Q1 2026. Any Neutron slip would be punished.

Cash burn largely reflects $156.3 million in capex tied to Neutron and factory scale-up, investments management targets to unlock mid- to upper-20s operating margins long term. Prediction markets currently price a 63% probability of a down day on July 1, so near-term chop is likely.

I’d Buy This Dip, Carefully

My 24/7 Wall St. price target of $119.58 reflects a buy with 50% confidence. The tipping factor is backlog conversion: 36% of the $2.2 billion backlog is expected to convert to revenue within 12 months. The $95 to $100 zone looks like a technically interesting reload area if Neutron milestones stay on track.

The setup weakens if the debut launch slips into 2027 or if another large ATM raise arrives before profitability inflects. For patient investors, the risk-reward tilts favorably after the June reset.

Here is where our model projects Rocket Lab could trade, blending our five-year base case with bull-side upside from Neutron reusability and space-based services.

These projections assume Rocket Lab executes Neutron on schedule and continues converting defense backlog at current margins. Significant upside or downside could result from Neutron reusability outcomes, further large SDA or Golden Dome awards, or execution stumbles in the Mynaric, Motiv, and Geost integrations.

Contact [email protected] for any questions or corrections.